NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
D Daley, VR Mani, N Mohan, N Akkad… - Journal of Experimental …, 2017 - rupress.org
The tumor microenvironment (TME) in pancreatic ductal adenocarcinoma (PDA) is
characterized by immune tolerance, which enables disease to progress unabated by …
characterized by immune tolerance, which enables disease to progress unabated by …
[PDF][PDF] NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
D Daley, VR Mani, N Mohan, N Akkad… - J. Exp …, 2017 - dukespace.lib.duke.edu
Pancreatic ductal adenocarcinoma (PDA) is a devastating disease in which the mortality rate
approaches the incidence rate (Yadav and Lowenfels, 2013). PDA is almost invariably …
approaches the incidence rate (Yadav and Lowenfels, 2013). PDA is almost invariably …
NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
D Daley, VR Mani, N Mohan… - The Journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
The tumor microenvironment (TME) in pancreatic ductal adenocarcinoma (PDA) is
characterized by immune tolerance, which enables disease to progress unabated by …
characterized by immune tolerance, which enables disease to progress unabated by …
[HTML][HTML] NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
D Daley, VR Mani, N Mohan, N Akkad… - The Journal of …, 2017 - ncbi.nlm.nih.gov
The tumor microenvironment (TME) in pancreatic ductal adenocarcinoma (PDA) is
characterized by immune tolerance, which enables disease to progress unabated by …
characterized by immune tolerance, which enables disease to progress unabated by …
NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
D Daley, VR Mani, N Mohan, N Akkad… - Journal of Experimental …, 2017 - cir.nii.ac.jp
抄録< jats: p> The tumor microenvironment (TME) in pancreatic ductal adenocarcinoma
(PDA) is characterized by immune tolerance, which enables disease to progress unabated …
(PDA) is characterized by immune tolerance, which enables disease to progress unabated …
[PDF][PDF] NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
D Daley, VR Mani, N Mohan, N Akkad, GSDB Pandian… - 2017 - researchgate.net
Pancreatic ductal adenocarcinoma (PDA) is a devastating disease in which the mortality rate
approaches the incidence rate (Yadav and Lowenfels, 2013). PDA is almost invariably …
approaches the incidence rate (Yadav and Lowenfels, 2013). PDA is almost invariably …
NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma.
D Daley, VR Mani, N Mohan, N Akkad… - The Journal of …, 2017 - europepmc.org
The tumor microenvironment (TME) in pancreatic ductal adenocarcinoma (PDA) is
characterized by immune tolerance, which enables disease to progress unabated by …
characterized by immune tolerance, which enables disease to progress unabated by …
[HTML][HTML] NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
D Daley, VR Mani, N Mohan, N Akkad… - Journal of Experimental …, 2017 - rupress.org
The tumor microenvironment (TME) in pancreatic ductal adenocarcinoma (PDA) is
characterized by immune tolerance, which enables disease to progress unabated by …
characterized by immune tolerance, which enables disease to progress unabated by …
[PDF][PDF] NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
D Daley, VR Mani, N Mohan, N Akkad… - J. Exp …, 2017 - dukespace.lib.duke.edu
Pancreatic ductal adenocarcinoma (PDA) is a devastating disease in which the mortality rate
approaches the incidence rate (Yadav and Lowenfels, 2013). PDA is almost invariably …
approaches the incidence rate (Yadav and Lowenfels, 2013). PDA is almost invariably …
[PDF][PDF] NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
D Daley, VR Mani, N Mohan, N Akkad, GSDB Pandian… - 2017 - researchgate.net
Pancreatic ductal adenocarcinoma (PDA) is a devastating disease in which the mortality rate
approaches the incidence rate (Yadav and Lowenfels, 2013). PDA is almost invariably …
approaches the incidence rate (Yadav and Lowenfels, 2013). PDA is almost invariably …